Literature DB >> 12914210

[Primary investigation on the changing mode of plasma specific IgG antibody in SARS patients and their physicians and nurses].

Guobin Xu1, Haiying Lu, Jie Li, Yonghua Li, Zhenru Feng, Na Hou, Guangfa Wang, Zhen-dong Zhao, Guohua Zhang, Cunling Yan, Haixia Li, Xiaoming Gao, Xiaoyuan Xu, Guiqiang Wang, Hui Zhuang.   

Abstract

OBJECTIVES: To primarily investigate the changing mode of anti-SARS coronavirus IgG antibody in clinically diagnosed SARS patients and the possibility of subclinical infection in physicians and nurses through close association with SARS patients.
METHODS: The plasma levels of anti-SARS coronavirus IgG antibody of 57 normal subjects, 127 physicians and nurses worked in SARS wards for one month and 73 SARS patients with different course of SARS were measured by enzyme linked immunosorbent assay.
RESULTS: Plasma anti-SARS coronavirus IgG antibody was not detected in normal subjects and the clinical personnel. After 0-7 days, 8-10 days, 11-14 days, 15-20 days of onset of disease, the positive rates were 0.33%, 52%, 86% respectively, and the general positive rate was 61%.
CONCLUSION: The specificity and sensitivity of ELISA to detect plasma anti-SARS IgG antibody were satisfactory. Cases with positive reaction could be diagnosed as patients already infected by the virus. The specific IgG antibody didn't emerge in some patients in the early stage of the disease, and the negative results didn't indicate that they were not infected. And follow-up investigation should be made in those patients. Unlike common epidemic infectious diseases, SARS probably hadn't the potentiality of subclinical infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914210

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  5 in total

1.  Specific immunoglobulin g antibody detected in umbilical blood and amniotic fluid from a pregnant woman infected by the coronavirus associated with severe acute respiratory syndrome.

Authors:  Xiugao Jiang; Xing Gao; Han Zheng; Meiying Yan; Weili Liang; Zhujun Shao; Wei Li; Enmin Zhang; Yuan Hu; Rong Hai; Dongzheng Yu; Biao Kan; Jianguo Xu
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

2.  Emergency medical services utilization during an outbreak of severe acute respiratory syndrome (SARS) and the incidence of SARS-associated coronavirus infection among emergency medical technicians.

Authors:  Patrick Chow-In Ko; Wen-Jone Chen; Matthew Huei-Ming Ma; Wen-Chu Chiang; Chan-Ping Su; Chien-Hua Huang; Tsung-Chien Lu; Fuh-Yuan Shih; Fang-Yue Lin
Journal:  Acad Emerg Med       Date:  2004-09       Impact factor: 3.451

3.  Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia.

Authors:  Timothy T C Yip; Johnny W M Chan; William C S Cho; Tai-Tung Yip; Zheng Wang; Ting-Lok Kwan; Stephen C K Law; Dominic N C Tsang; John K C Chan; King-Chung Lee; Wai-Wai Cheng; Victor W S Ma; Christine Yip; Cadmon K P Lim; Roger K C Ngan; Joseph S K Au; Angel Chan; Wilina W L Lim
Journal:  Clin Chem       Date:  2004-09-13       Impact factor: 8.327

4.  Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine.

Authors:  Min-Sheng Zhu; Ying Pan; Hua-Qun Chen; Yue Shen; Xiao-Chun Wang; Yong-Jun Sun; Kai-Hua Tao
Journal:  Immunol Lett       Date:  2004-04-15       Impact factor: 3.685

5.  Application of ProteinChip array profiling in serum biomarker discovery for patients suffering from severe acute respiratory syndrome.

Authors:  Timothy T C Yip; William C S Cho; Wai Wai Cheng; Johnny W M Chan; Victor W S Ma; Tai-Tung Yip; Christine N B Lau Yip; Roger K C Ngan; Stephen C K Law
Journal:  Methods Mol Biol       Date:  2007
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.